REFERENCES
- Kerjaschki D. Caught flat-footed: Podocyte damage and the molecular bases of focal glomerulosclerosis. J Clin Invest 2001; 108(11):1583–1587.
- Pagtalunan ME, Miller PL, Jumping-Eagle S, Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997; 99(2):342–348.
- Nakamura T, Ushiyama C, Suzuki S, Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 2000; 15(9):1379–1383.
- Nakamura T, Ushiyama C, Suzuki S, Urinary podocytes for the assessment of disease activity in lupus nephritis. Am J Med Sci 2000; 320(2):112–116.
- Kestila M, Lenkkeri U, Mannikko M, Positionally cloned gene for a novel glomerular protein – nephrin – is mutated in congenital nephrotic syndrome. Mol Cell 1998; 1(4):575–582.
- Lenkkeri U, Mannikko M, McCready P, Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations. Am J Hum Genet 1999; 64(1):51–61.
- Patrakka J, Tryggvason K. Nephrin – A unique structural and signaling protein of the kidney filter. Trends Mol Med 2007; 13(9):396–403.
- Garovic VD, Wagner SJ, Petrovic LM, Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia. Nephrol Dial Transplant 2007; 22(4):1136–1143.
- Collino F, Bussolati B, Gerbaudo E, Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol 2008; 294(5):F1185–F1194.
- ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002; 99(1):159–167.
- Levine RJ, Maynard SE, Qian C, Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350(7):672–683.
- Maynard SE, Min JY, Merchan J, Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111(5):649–658.
- Sugimoto H, Hamano Y, Charytan D, Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 2003; 278(15):12605–12608.
- Garovic VD, Wagner SJ, Turner ST, Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol 2007; 196(4):320, e321–e327.
- Hara M, Yanagihara T, Takada T, Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis. Am J Nephrol 1998; 18(1):35–41.
- Petermann A, Floege J. Podocyte damage resulting in podocyturia: A potential diagnostic marker to assess glomerular disease activity. Nephron Clin Pract 2007; 106(2):c61–c66.
- Yu D, Petermann A, Kunter U, Rong S, Shankland SJ, Floege J. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol 2005; 16(6):1733–1741.
- Osicka TM, Panagiotopoulos S, Jerums G, Comper WD. Fractional clearance of albumin is influenced by its degradation during renal passage. Clin Sci (Lond) 1997; 93(6):557–564.